News

Rosatom commissioned largest wind farm in Russia
In total, by 2024, Rosatom will commission wind power plants with a total capacity of about 1.2 GW.
Russian government provided $8.12 mln of support to SMEs
"In total, there were more than 4.5 mln instances of state support for the two years worth about 600 bln rubles," Prime Minister Mikhail Mishustin said.
Russian Direct Investment Fund negotiates delivery of Sputnik V vaccine to Bolivia
The agreement will make it possible to provide the vaccine for more than 20% of the country’s population.
Kremlin lists economic issues and rise in poverty among main challenges of 2020
According to the Russian Ministry of Economic Development, Russia’s GDP is likely to drop by 3.8% in 2020.
Argentina reports over 300,000 applications for vaccination with Russia’s Sputnik V
More than 300,000 citizens of Argentina’s largest province of Buenos Aires have applied for receiving Russia’s Sputnik V coronavirus vaccine, the regional government’s press service said.
Russia ranks third in the world by number of CCTV cameras

There are 93 cameras per 1,000 people in Russia, according to a study.
Business sector to pour $2.6 bln into Russian tourism projects in coming 2-3 years
The current task of the Federal Agency for Tourism is to create such conditions both regarding taxes, cheap loans, co-financing of various events, and regarding joint efforts of regions and businesses that will ensure development of all that.
Russian government plans to sign at least 1,000 investment protection agreements
A system for support of investments by medium businesses at the regional level also undergoes deployment at present.
Moscow allocated $1.2 bln to support businesses in 2020
The head of the Department of Entrepreneurship and Innovative Development of Moscow also noted that in 2021 the authorities plan to increase the number of subsidies for small and medium-sized businesses.
AstraZeneca and Sputnik V investor and developer sign agreement of cooperation on vaccines
The sides agreed to boost research and business relations that will include studies to explore the potential of a combined use of the Russian Sputnik V vaccine and the AZD1222 preparation developed by the British-Swedish AstraZeneca.